Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FAMOTIDINE 20 MG TABLET

FAMOTIDINE
$0.1410per EA
OTC

Strength

20 mg/1

Manufacturer

Precision Dose Inc.

NDC

68094005465

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

FAMOTIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077351

On Market Since

3/28/2024

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price History

1W

0.0%

1M

-2.1%

3M

-3.0%

6M

-4.5%

1Y

-1.8%

3Y

N/A

5Y

N/A

All

-1.4%

Generic Alternatives

Save up to 78%

1 alternative • Same active ingredient

FAMOTIDINE 20 MG TABLET
Generic
67877084205•Ascend Laboratories, LLC
$0.0310
Save 78%

Related Drugs

Same classification

FAMOTIDINE 20 MG TABLET
Generic
63739064510•McKesson
$0.0303
per EA
FAMOTIDINE 20 MG TABLET
Generic
00172572860•Teva Pharmaceuticals USA Inc.
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
00172572870•Teva Pharmaceuticals USA Inc.
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
00172572880•Teva Pharmaceuticals USA Inc.
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
00904719306•Major Pharmaceuticals
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
00904719361•Major Pharmaceuticals
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
31722001701•Camber Pharmaceuticals Inc.
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
31722001710•Camber Pharmaceuticals Inc.
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
50268029915•AvPAK
$0.0310
per EA
FAMOTIDINE 20 MG TABLET
Generic
55111011901•Dr. Reddy's Laboratories Inc.
$0.0310
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy